As of today (2026-07-07), the Forward Annual Dividend Yield of Supriya Lifescience is 0.10%.
As of today (2026-07-07), the Trailing Annual Dividend Yield of Supriya Lifescience is 0.10%.
NSE:SUPRIYA's Forward Dividend Yield % is ranked worse than 97.28% of 147
companies
in the Biotechnology industry
Industry Median: 1.3
vs NSE:SUPRIYA: 0.10
During the past 12 months, Supriya Lifescience's average Dividends Per Share Growth Rate was 25.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 18.60% per year.
During the past 8 years, the highest 3-Year average Dividends Per Share Growth Rate of Supriya Lifescience was 18.60% per year. The lowest was 18.60% per year. And the median was 18.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Supriya Lifescience Forward Dividend Yield % Related Terms
NSE:SUPRIYA vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Supriya Lifescience's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supriya Lifescience Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Supriya Lifescience's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Supriya Lifescience's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Supriya Lifescience Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 1.000000
2025-09-04
2025-09-05
2025-09-24
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Supriya Lifescience's Forward Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 0.10% mean?
Supriya Lifescience (NSE:SUPRIYA) has a Forward Dividend Yield % of 0.10% as of Jul. 07, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Supriya Lifescience and its competitors. According to the industry distribution chart, Supriya Lifescience ranks #143 out of 147 companies in the Biotechnology industry, placing it in the top 97.3%.
Is Supriya Lifescience's Forward Dividend Yield % too high?
Supriya Lifescience's current Forward Dividend Yield % is 0.10%. The Biotechnology industry median Forward Dividend Yield % is 1.30. Supriya Lifescience's value of 0.10% is 92.3% below this industry median. Based on the distribution chart, Supriya Lifescience ranks #143 out of 147 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Supriya Lifescience has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Supriya Lifescience's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Supriya Lifescience ranks #143 out of 147 companies for Forward Dividend Yield %. This places Supriya Lifescience in the lower half of its industry. The industry median Forward Dividend Yield % is 1.30. Supriya Lifescience's value of 0.10% is 92.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.30, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Supriya Lifescience's current Forward Dividend Yield % of 0.10% is 92.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Supriya Lifescience and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supriya Lifescience's current Forward Dividend Yield % is 0.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supriya Lifescience stock overvalued right now?
Based on GuruFocus' analysis, Supriya Lifescience (NSE:SUPRIYA) is currently considered Fairly Valued. The stock's GF Value™ is ₹806.98, compared to a current price of ₹865.20 — trading 7.2% above its estimated fair value. The current Forward Dividend Yield % is 0.10% and 92.3% below the Biotechnology industry median of 1.30. Supriya Lifescience's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Supriya Lifescience (NSE:SUPRIYA), the current Forward Dividend Yield % is 0.10% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supriya Lifescience (NSE:SUPRIYA) Overvalued in 2026?
Based on GuruFocus' analysis, Supriya Lifescience stock appears to be overvalued.
The current stock price of ₹865.20 is trading 7.2% above its estimated GF Value™ of ₹806.98.
GuruFocus considers Supriya Lifescience to be Fairly Valued.
Key valuation signals for NSE:SUPRIYA:
Forward Dividend Yield %: 0.10%
GF Value™: ₹806.98 vs. price of ₹865.20 (7.2% above fair value)
Industry Position: 92.3% below the Biotechnology median (#143 of 147)
No single metric tells the full story. See the NSE:SUPRIYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
82GF Score
Get the complete analysis for NSE:SUPRIYA
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUPRIYA has been successfully added to your 